Kamdem Félicité, Mapoure Yacouba, Hamadou Ba, Souksouna Fanny, Doualla Marie Solange, Jingi Ahmadou Musa, Kenmegne Caroline, Lekpa Fernando Kemta, Fenkeu Jaff Kweban, Imandy Gisèle, Mefo'o Jean Pierre Nda, Luma Henry
Internal Medicine Service, Douala General Hospital, Douala, Cameroon.
Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon.
Vasc Health Risk Manag. 2018 Dec 6;14:401-408. doi: 10.2147/VHRM.S165960. eCollection 2018.
The prevalence of peripheral artery disease (PAD) is not well known among HIV-infected patients in Africa. The aim of this study was to determine the prevalence and associated risk factors of PAD among HIV-infected patients at the Douala General Hospital (DGH).
This was a cross-sectional descriptive and analytic study between November 2015 and April 2016. We recruited patients aged ≥21 years, diagnosed with HIV infection, and who were receiving care at the DGH. We collected sociodemographic data and past medical history of patients. We measured their ankle-brachial index (ABI). We defined PAD as an ABI <0.9. We also measured their fasting blood glucose and lipid profile.
We recruited 144 patients for this study. The mean age was 46±9 years, and 72.2% were females. Of which, 89% were on antiretroviral treatment (ARV). Their mean CD4+ T lymphocytes count was 451±306 cells/mm. Their mean ABI was 1.12±0.17 and 1.07±0.11, respectively, on the left and right legs (>0.05). The prevalence of PAD was 6.9% (95% CI: 3.4-12.4), and 60% of patients with PAD were symptomatic. After adjusting for age, sex and ARV, ARV treatment was protective (aOR: 0.18, [95% CI: 0.04-0.82], =0.034), while WHO stages III or IV was associated with PAD (aOR: 11.1, [95% CI: 2.19-55.92], =0.004).
The prevalence of PAD was not as high as expected in this group of patients with high cardiovascular risk infected with HIV. Advanced HIV disease was associated with PAD, while ARV was protective.
在非洲,外周动脉疾病(PAD)在HIV感染患者中的患病率尚不清楚。本研究的目的是确定杜阿拉总医院(DGH)HIV感染患者中PAD的患病率及相关危险因素。
这是一项2015年11月至2016年4月期间的横断面描述性和分析性研究。我们招募了年龄≥21岁、被诊断为HIV感染且正在DGH接受治疗的患者。我们收集了患者的社会人口学数据和既往病史。我们测量了他们的踝臂指数(ABI)。我们将PAD定义为ABI<0.9。我们还测量了他们的空腹血糖和血脂谱。
我们招募了144名患者进行本研究。平均年龄为46±9岁,72.2%为女性。其中,89%正在接受抗逆转录病毒治疗(ARV)。他们的平均CD4+T淋巴细胞计数为451±306个细胞/mm。他们左右腿的平均ABI分别为1.12±0.17和1.07±0.11(>0.05)。PAD的患病率为6.9%(95%CI:3.4-12.4),60%的PAD患者有症状。在调整年龄、性别和ARV后(aOR:0.18,[95%CI:0.04-0.82],P=0.034),ARV治疗具有保护作用,而世界卫生组织III期或IV期与PAD相关(aOR:11.1,[95%CI:2.19-55.92],P=0.004)。
在这组具有高心血管风险的HIV感染患者中,PAD的患病率并不像预期的那么高。晚期HIV疾病与PAD相关,而ARV具有保护作用。